Korean Market
OWNR
Daesung Microbiological Labs
★

Insilico Increases Stake in Daesung Microbiological Labs to 39.24% via Open Market Purchase, Signaling Confidence

 
OWNR
Daesung Microbiological Labs
★

Insilico, the largest shareholder, slightly increases stake to 39.01% via open market purchase, signaling management stability and positive shareholder value

 
OWNR
Daesung Microbiological Labs
★

CEO Seunghoon Choi Increases Stake to 1% via Open Market Purchase, Signaling Management Confidence

 
OWNR
Daesung Microbiological Labs
★

CEO Seunghoon Choi increases stake by 0.09%p via open market purchase... small but positive insider confidence signal

 
OWNR
Daesung Microbiological Labs
★

CEO Seunghoon Choi Slightly Increases Stake to 0.80% via Open Market Purchase... Small but Positive Signal of Insider Confidence

 
OWNR
Daesung Microbiological Labs
★

Major Shareholder Insilico Increases Stake to 38.84% via Open Market Purchase... Positive Signal for Shareholder Value

 
OWNR
Daesung Microbiological Labs
★★★★

Insilico acquires 38.6% stake in Daesung Microbiological via OTC purchase at KRW 11,000 per share, signaling premium valuation and enhanced shareholder value

 
OWNR
Daesung Microbiological Labs
★

CEO Seunghoon Choi buys 3,149 common shares in open market... stake rises to 0.77%

 
OWNR
Daesung Microbiological Labs
★

CEO Seunghoon Choi Increases Stake to 0.69% with Purchase of 5,476 Shares

 
OWNR
Daesung Microbiological Labs
★

CEO Seunghoon Choi Increases Stake by 0.25% via Open Market Purchase (9,614 Shares at 6,752 Won)

 
OWNR
Daesung Microbiological Labs
★

CEO Seunghoon Choi buys 8,000 shares on market, raising stake to 0.29%

 
OWNR
Daesung Microbiological Labs
★

Report on Ownership of Specific Securities by Executives and Major Shareholders (No Changes)

 
PERI
Daesung Microbiological Labs
★

Daesung Microbiological Labs Changes Largest Shareholder and Appoints New Management; Q1 Sales Slightly Down, Net Loss Continues